POSTER SESSION VI Wednesday, March 02, 2005   —  1:00 - 4:00 PM Convention Center, Exhibit Hall B GENITOURINARY PATHOLOGY 98 Metastasis-Associated Gene 1 (MTA1) Is Associated with Prostate Cancer Specific Death (671) MD Hofer, L Mucci, O Andren, R Kim, PW Kantoff, JE Johansson, MA Rubin - Brigham and Women's Hospital, Boston; Harvard Medical School, Boston; Harvard School of Public Health, Boston; Orebo University Hospital Orebro, Sweden; Dana-Farber Cancer Institute, Boston 99 Increased Expression of Ephrin A2 (Eph A2) Tyrosine Kinase in Metastatic Prostate Cancer (28) R Dhir, SI Bastacky, M Acquafondata, T McHale, AV Parwani - University of Pittsburgh, Pittsburgh, PA 100 Expression of GSK-3 Is Increased in Metasstatic Prostate Cancer (582) G Ayala, R Li, H Dai, A Frolov, T Wheeler - Baylor College of Medicine, Houston, TX 101 Immunoreactivity of Anti-P501S, a Novel Prostate Specific Marker, and Anti-PSA in Human Metastatic Prostate Cancer (761) KM Sojka, BO Spaulding, RM Bretzing, GB Nielsen, R Welcher - DakoCytomation, Carpinteria, CA 102 Increased Pim-2 Is an Adverse Indicator of Aggressive Disease and Is Increased in Perineural Invasion (620) H Dai, T Wheeler, R Li, A Frolov, G Ayala - Baylor College of Medicine, Houston, TX 103 Prostate Specific Membrane Antigen (PSMA) Expression in Primary Prostatic Adenocarcinoma: Comparison of Expression by Gleason Grade, Hormonal Status and Metastatic Potential (572) HA Al-Ahmadie, S Prakash, P Gregor, S Olgac, HI Scher, VE Reuter - Memorial Sloan-Kettering Cancer Center, New York, NY 104 Increased Expression of Fatty Acid Synthase in Prostate Adenocarcinoma Following Total Androgen Ablation (746) AA Roma, R Montironi, M Loda, C Magi-Galluzzi - Cleveland Clinic Foundation, Cleveland, OH; University of Ancona, Ancona, Italy; Dana Farber Cancer Institute, Brigham & Women's Hospital, Boston, MA 105 Activation of the ATM-p53 Cell Cycle Checkpoint by Prostate Cancer Radiotherapy: An Immunohistochemical Study (617) H Cole, A Meng, P Warde, N Fleshner, L Klotz, J Sweet, R Bristow - Princess Margaret Hospital, Toronto, ON, Canada; Sunnybrook and Women's College Health Sciences Centre, Toronto, ON, Canada 106 Nuclear Expression of Phospho-Akt in Prostatic Adenocarcinoma, Prostatic Intraepithelial Neoplasia and Benign Nodular Hyperplasia (744) J Richmond, W Trotman, G Philips, T Trainer - University of Vermont College of Medicine, Burlington, VT; Fletcher Allen Health Care, Burlington, VT 107 Smad4 Protein Is Expressed in Prostatic Adenocarcinomas (PACs) and Correlates with Grade, Stage and DNA Ploidy (747) JS Ross, GM Sheehan, CE Sheehan, HAG Fisher, RP Kaufman, Jr., BVS Kallakury - Albany Medical College, Albany, NY; Georgetown University Hospital, Washington, DC 108 Prostate and Pancreatic Cancers Cause Increased Neurite Outgrowth In Vitro (735) MS Powell, H Dai, MR Anderson, TM Wheeler, GE Ayala - Baylor College of Medicine, Houston, TX 109 CD90/Thy1 Is Overexpressed by Stromal Cells Associated with Primary Prostate Carcinoma (775) LD True, A Huang, I Coleman, PS Nelson, AY Liu - University of Washington, Seattle, WA; Fred Hutchinson Cancer Center, Seattle, WA 110 Increased Stat3 and Stat5 Protein Expression Correlates with Aggressive Biologic Phenotype in Prostatic Adenocarcinomas (PACs) (688) BVS Kallakury, GM Sheehan, CE Sheehan, HAG Fisher, RP Kaufman, Jr, JS Ross - Georgetown University Hospital, Washington, DC; Albany Medical College, Albany, NY 111 Cytoplasmic Displacement of p27 Is an Independent Predictor of Biochemical Recurrence in Prostate Cancer after Radical Prostatectomy (704) R Li, T Wheeler, H Dai, M Sayeeduddin, A Frolov, G Ayala - Baylor College of Medicine, Houston, TX 112 Lack of Inducible Nitric Oxide Synthase Expression in Most Prostatic Adenocarcinomas (697) BH Lee, WR Gage, V Marchi, J Hicks, WG Nelson, AM De Marzo - The Johns Hopkins University School of Medicine, Baltimore, MD; SUNY, Buffalo, NY 113 Immunohistochemical Expression of EZH2 in Prostatic Adenocarcinomas (PACs) (689) BVS Kallakury, CE Sheehan, HAG Fisher, RP Kaufman, Jr, JS Ross - Georgetown University Hospital, Washington, DC; Albany Medical College, Albany, NY 114 Evaluation of Immunohistochemical Expression of NB-1, as a Marker for Neoplastic Transformation in the Prostate (663) RN Hari, S Ferrone, M Acquafondata, M Notaro, T Whiteside, R Dhir - University of Pittsburgh, Pittsburgh, PA 115 Decreased Expression of PRMT5 Is Associated with Prostate Cancer (659) CC Guo, X Zhang, H Yee, L Chiriboga, J Melamed, P Lee - New York University School of Medicine, New York, NY 116 Multi-Institution Automated Image Analysis of PTEN Protein in Prostatic Adenocarcinoma (643) DA Faith, D Ertoy-Baydar, YS Spolter, EA Platz, MA Rubin, G Ayala, AM De Marzo - Johns Hopkins School of Medicine, Baltimore, MD; Dana Farber Cancer Institute, Boston, MA; Baylor College of Medicine, Houston, TX; The Bloomberg School of Public Health, Baltimore, MD 117 Overexpression of WWOX Protein in Prostate Cancer (642) D Ertoy-Baydar, DA Faith, G Guler, K Huebner, AM De Marzo - The Johns Hopkins University School of Medicine, Baltimore, MD; Hacettepe University Hospital, Ankara, Turkey; Thomas Jefferson University, Philadelphia, PA 118 Proliferation and Apoptosis in Prostate Cancer and the Perineural Space: A Phenotypic Change Related to Survival (801) N Yanagisawa, R Li, H Dai, A Diaz De Vivar, T Wheeler, T Thompson, M Sayeeduddin, G Ayala - Baylor College of Medicine, Houston, TX 119 Potential Roles of Cytologic T-Lymphocytes and Nature Killer Cells in Prostate Basal Cell Layer Disruptions and Tumor Invasion (809) C Zhao, C Mannion, YG Man - Armed Forces Institute of Pathology, Washington, DC; Hackensack Medical Center, Hackensack, NJ 120 Alteration of Prognostic Value of COX-2 in Prostate Cancer by Maspin (606) M Che, RS Singh, S H. Khayyata, R Ali-Fehmi, W Sakr, D Grignon - Wayne State University, Detroit, MI 121 p16 Is Upregulated in Proliferative Inflammatory Atrophy of the Prostate (644) DA Faith, S Han, DK Lee, AM De Marzo, DF Jarrard - Johns Hopkins School of Medicine, Baltimore, MD; University of Wisconsin School of Medicine, Madison, WI 122 Intraprostatic Spermatozoa (IS): Zonal Distribution and Association with Atrophy (608) X Chen, J Zhao, S Salim, FU Garcia - Drexel University College of Medicine, Philadelphia, PA 123 Specialized Stromal Tumors of the Prostate: A Clinicopathologic Study of 44 Cases (667) M Herawi, JI Epstein - The Johns Hopkins Hospital, Baltimore, MD 124 Non-Hodgkins Lymphoma (NHL) of the Prostate: Emphasis on Useful Diagnostic Features (569) NA Abrahams, SL Johansson, D Weisenburger - University of Nebraska Medical Center, Omaha, NE 125 Pleomorphic Adenocarcinoma of the Prostate with Bizarre Giant Cells: Report of 6 Cases (729) A Parwani, M Herawi, JI Epstein - Currently at University of Pittsburgh Medical Center, Pittsburgh, PA; The Johns Hopkins Hospital, Baltimore, MD 126 Expression of Novel Markers in Small Cell Carcinoma of the Prostate: Possible Therapeutic Targets (803) JL Yao, PA Bourne, JY Lei, X Yang, SK Tickoo, Z Liu, J Huang, PA Di Sant'Agnese - University of Rochester Medical Center, Rochester, NY; Northwestern Memorial Hospital, Chicago, IL; Weill Medical College of Cornell University, New York, NY; University of Florida at Jacksonville, Jacksonville, FL 127 Adenoid Cystic/Basal Cell Carcinoma of the Prostate Expresses HER-2/neu (676) KA Iczkowski, GT MacLennan, DG Bostwick, KL Ferguson, R Montironi - University of Florida, Gainesville, FL; Veterans Administration Medical Center, Gainesville, FL; University Hospitals, Cleveland, OH; Bostwick Laboratories, Richmond, VA; Central Coast Pathology, San Luis Obispo, CA; University of Ancona Hospital, Ancona, Italy 128 Reporting of Testicular Germ Cell Tumors: Are the Clinically Relevant Data in the Pathology Report? (656) JA Gomez, P Tamboli - The University of Texas M. D. Anderson Cancer Center, Houston, TX 129 Tissue Microarray of the British Testicular Tumour Panel Series: Mining a Historical Archive (592) DM Berney, K Argyle, A Clear, RTD Oliver - St Bartholomew's Hospital, Queen Mary University, London, United Kingdom 130 Evaluation of p63 Expression in Testicular Germ Cell Tumors (639) PO Emanuel, PD Unger, L Gan, DE Burstein - Mount Sinai School of Medicine, New York, NY 131 Tyrosine Kinases in Seminomas (770) RF Tibbs, A Malpica, AO Reyes - U.T. M.D. Anderson Cancer Center, Houston, TX 132 OCT4 Immunoreactivity in Testicular Germ Cell Tumors: Assessment of Diagnostic Utility and Histogenetic Implications (680) KV Inamdar, MD Linden, AT Savera - Henry Ford Hospital, Detroit, MI 133 Primary Retroperitoneal Lymph Node Dissection in Pathologic Stage II Testicular Germ Cell Tumors: A Clinicopathological Study (573) HA Al-Ahmadie, S Olgac, J Stasi, J Sheinfeld, VE Reuter - Memorial Sloan-Kettering Cancer Center, New York, NY 134 Malignant Mesotheliomas of Tunica Vaginalis (621) CJ Davis, IA Sesterhenn - Armed Forces Institute of Pathology, Washington, DC 135 Primary Testicular Lymphoma: Retrospective Clinicopathological Study of 34 Cases (570) MA Al-Abbadi, ET Hattab, MS Tarawneh, TM Ulbright, A Orazi - Wayne State University, Detroit, MI; Indiana University/School of Medicine, Indianapolis, IN; University of Jordan, Amman, Jordan 136 Papillary Squamous Cell Carcinoma of the Penis. A Report of 18 Cases (605) A Chaux, EF Velazquez, J Torres, AL Cubilla - Instituto de Patologia e Investigacion., Asuncion, Paraguay; NYU Medical Center, New York, NY 137 Any Proportion of Histological Grade 3 Is Related to Metastasis in SCC of Penis. An Electronically Quantified Study of Proportions of Grades (618) AL Cubilla, A Chaux, R Pffanl, J Torres, JE Barreto, EF Velazquez - Instituto de Pathologia e Investigacion, Asuncion, Paraguay; NYU Medical Center, New Tork, NY 138 Intuitive vs Electronic Quantification of Proportions of Grades in Squamous Cell Carcinomas of the Penis (619) AL Cubilla, A Chaux, J Torres, R Pfannl, EF Velazquez - Instituto de Patologia e Investigacion, Asuncion, Paraguay; NYU Medical Center, New York, NY 139 The Morphological Spectrum of Penile Condylomatous Tumors. A Report of 44 Cases and a Re Evaluation of the Buschke Lowenstein Tumor-Giant Condyloma Concept (745) IM Rodriguez, EF Velazquez, J Torres, JE Barreto, AL Cubilla - Instituto de Patologia e Investigacion, Asuncion, Paraguay; NYU Medical Center, New York, NY